<!DOCTYPE html>
<html>
<head>
    <title>全文阅读--XML全文阅读--中国知网</title>
    <link rel="icon" href="/kxreader/favicon.ico" />
    <link rel="shortcut Icon" href="/kxreader/favicon.ico" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="文献 XML KBASE CNKI 中国知网" />
    <meta name="description" content="XML文献检索" />
    <link href="/kxreader/Content/css/detail?v=NOOK-mvTMnxl11s6oPYV0boPXN3iP4N7Rc-A56nk4KI1" rel="stylesheet"/>

    <script type="text/javascript">
        var APPPATH = '/kxreader';
    </script>
</head>

<body>
    
<script type="text/javascript" src="//login.cnki.net/TopLogin/api/loginapi/get?type=top&amp;localCSS=&amp;returnurl=%2f%2fkns.cnki.net%2fKXReader%2fDetail%3fTIMESTAMP%3d637141659847295000%26DBCODE%3dCJFD%26TABLEName%3dCJFDLAST2019%26FileName%3dXXGK201902030%26RESULT%3d1%26SIGN%3dvn0fYD3jloSlTrrottJjPAxjBsE%253d"></script>

<div id="headerBox" class="header">
    <div class="topbar">
        <div class="textalign">
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201902030&amp;align=md">
                <i class="icon-cen active" title="居中对齐"></i>
            </a>
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201902030&amp;align=lt">
                <i class="icon-left " title="左对齐"></i>
            </a>
        </div>
        <h6 class="free-tip"><i class="icon"></i>HTML阅读开放试用阶段，欢迎体验！</h6>
    </div>
</div>

    



<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201902030&amp;v=MDMxOTZaSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWptVkx6QlBUWE1aYkc0SDlqTXJZOUc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>

    <div class="main">

        

    <div class="sidebar-a">
        <!--sidebar start-->
        <div class="sidenav">
            <div class="arrow"><span></span></div>
            <!--sidebar_list start-->
            <dl class="sidenav-list">
                    <dt class="tit">目录结构</dt>
                            <dd class="guide">
                                    <p><a href="#65" data-title="&lt;b&gt;1 冠状动脉微血管功能障碍的分型和临床特点&lt;/b&gt; "><b>1 冠状动脉微血管功能障碍的分型和临床特点</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#68" data-title="1.1 原发性稳定型微血管性心绞痛 (MVA) ">1.1 原发性稳定型微血管性心绞痛 (MVA) </a></li>
                                                <li><a href="#70" data-title="1.2 原发性急性微血管性心绞痛">1.2 原发性急性微血管性心绞痛</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#74" data-title="2.1 结构性机制 ">2.1 结构性机制</a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#76" data-title="2.2 功能性机制 ">2.2 功能性机制</a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#122" data-title="2.2.1 内皮依赖的血管舒张改变:">2.2.1 内皮依赖的血管舒张改变:</a></li>
                                                <li><a href="#123" data-title="2.2.2 非内皮依赖血管舒张改变:">2.2.2 非内皮依赖血管舒张改变:</a></li>
                                                <li><a href="#124" data-title="2.2.3 血管收缩:">2.2.3 血管收缩:</a></li>
                                                <li><a href="#125" data-title="2.2.4 血管内阻塞:">2.2.4 血管内阻塞:</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#81" data-title="2.3 血管外机制 ">2.3 血管外机制</a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#126" data-title="2.3.1 管腔外压力:">2.3.1 管腔外压力:</a></li>
                                                <li><a href="#127" data-title="2.3.2 舒张时间缩短:">2.3.2 舒张时间缩短:</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#84" data-title="&lt;b&gt;3 冠状动脉微循环的评估方法&lt;/b&gt; "><b>3 冠状动脉微循环的评估方法</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#88" data-title="&lt;b&gt;4 冠状动脉微循环功能障碍的治疗&lt;/b&gt; "><b>4 冠状动脉微循环功能障碍的治疗</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#" data-title="文内图表 ">文内图表</a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#73" data-title="&lt;b&gt;表&lt;/b&gt;1 &lt;b&gt;冠状动脉微血管功能障碍的发病机制&lt;/b&gt;"><b>表</b>1 <b>冠状动脉微血管功能障碍的发病机制</b></a></li>
                                                <li><a href="#86" data-title="&lt;b&gt;表&lt;/b&gt;2 &lt;b&gt;冠状动脉微循环的无创评估方法&lt;/b&gt;"><b>表</b>2 <b>冠状动脉微循环的无创评估方法</b></a></li>
                                                <li><a href="#87" data-title="&lt;b&gt;表&lt;/b&gt;3 &lt;b&gt;冠状动脉微循环障碍有创评估方法&lt;/b&gt;"><b>表</b>3 <b>冠状动脉微循环障碍有创评估方法</b></a></li>
                                    </ul>
                            </dd>
                                    <dd class="guide">
                                        <h6>
                                            <p><a href="#a_bibliography">参考文献</a> </p>
                                        </h6>
                                    </dd>

            </dl>
        </div>
        <!--sidebar end-->
        &nbsp;
        <!--此处有一空格符 勿删-->
    </div>

                <div class="sidebar-b three-collumn" style="width:0;">
            <div class="refer" style="width: 0;">
                <div class="arrow off" title="参考文献"><span></span></div>
                <div class="js-scrollbox" >
                    
                    <div class="subbox active">
                        <h4>
                            <span class="tit">参考文献</span>
                            <a class="close" href="javascript:void(0)">x</a>
                        </h4>
                        <div class="side-scroller">
                            <ul class="refer-list">
                                <li id="128">


                                    <a id="bibliography_1" title="Crea F, Camici PG, Bairey Merz CN.Coronary microvascular dysfunction:an update[J].Eur Heart J, 2014, 35 (17) :1101-1111." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Coronary microvascular dysfunction:an update">
                                        <b>[1]</b>
                                        Crea F, Camici PG, Bairey Merz CN.Coronary microvascular dysfunction:an update[J].Eur Heart J, 2014, 35 (17) :1101-1111.
                                    </a>
                                </li>
                                <li id="130">


                                    <a id="bibliography_2" title="Camici PG, Crea F.Coronary microvascular dysfunction[J].N Engl J Med, 2007, 356 (8) :830-840." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Coronary microvascular dysfunction">
                                        <b>[2]</b>
                                        Camici PG, Crea F.Coronary microvascular dysfunction[J].N Engl J Med, 2007, 356 (8) :830-840.
                                    </a>
                                </li>
                                <li id="132">


                                    <a id="bibliography_3" title="Suzuki H.Different definition of microvascular angina[J].Eur J Clin Incest, 2015, 45 (12) :1360-1366." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWDF81458BC15E3C0841E880681062EF078&amp;v=MTE0NDFIbnFyUkl6ZThmaVJiMlhDT052RlNpV1dyN0pJRnBtYUJ1SFlmT0dRbGZCckxVMDV0Qmh4THU0dzZFPU5pZmNhc1d3SDlYSnAvMDJaZTU2RHc4NXh4SVNuemQxUw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[3]</b>
                                        Suzuki H.Different definition of microvascular angina[J].Eur J Clin Incest, 2015, 45 (12) :1360-1366.
                                    </a>
                                </li>
                                <li id="134">


                                    <a id="bibliography_4" title="Kaul S, Newell JB, Chesler DA, et al.Quantitative thallium imaging fingings in patients with normal coronary angiographic findings and in clinically normal subjects[J].Am J Cardiol, 1986, 57 (8) :509-512." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Quantitative thallium imaging findings in patients with normal coronary angiographic findings and in clinically normal subjects">
                                        <b>[4]</b>
                                        Kaul S, Newell JB, Chesler DA, et al.Quantitative thallium imaging fingings in patients with normal coronary angiographic findings and in clinically normal subjects[J].Am J Cardiol, 1986, 57 (8) :509-512.
                                    </a>
                                </li>
                                <li id="136">


                                    <a id="bibliography_5" title="Cavusoglu Y, Entok E, Timuralp B, et al.Regional distribution and extent of perfusion abnormalities, and the lung to heart uptake ratios duing exercise thallium-201 SPECT imaging in petients with cardiac syndrome X[J].Can J Cardiol, 2005, 21 (1) :57-62." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Regional distribution and extent of perfusion abnormalities, and the lung to heart uptake ratios during exercise thallium-201 SPECT imaging in patients with cardiac syndrome X">
                                        <b>[5]</b>
                                        Cavusoglu Y, Entok E, Timuralp B, et al.Regional distribution and extent of perfusion abnormalities, and the lung to heart uptake ratios duing exercise thallium-201 SPECT imaging in petients with cardiac syndrome X[J].Can J Cardiol, 2005, 21 (1) :57-62.
                                    </a>
                                </li>
                                <li id="138">


                                    <a id="bibliography_6" title="Lamendola P, Lanza GA, Spinelli A, et al.Long-term prognosis of patients with cardiac syndrome X[J].Int J Cardiol, 2010, 140 (2) :197-199." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012300495105&amp;v=MjAyMTNPSUtEWHc4b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUYwVGFScz1OaWZPZmJLN0h0RE9ySTlGWQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[6]</b>
                                        Lamendola P, Lanza GA, Spinelli A, et al.Long-term prognosis of patients with cardiac syndrome X[J].Int J Cardiol, 2010, 140 (2) :197-199.
                                    </a>
                                </li>
                                <li id="140">


                                    <a id="bibliography_7" title="Bugiardini R, Manfrini O, Pizzi C, et al.Endothelial function predicts future development of coronary artery disease:a study of women with chest pain and normal coronary angiograms[J].Circulation, 2004, 109 (21) :2518-2523." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK12103000030716&amp;v=MjI1MTJaYks2SDlIUHI0OUZaT2dQQzMwL29CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGMFRhUnM9TmlmYw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[7]</b>
                                        Bugiardini R, Manfrini O, Pizzi C, et al.Endothelial function predicts future development of coronary artery disease:a study of women with chest pain and normal coronary angiograms[J].Circulation, 2004, 109 (21) :2518-2523.
                                    </a>
                                </li>
                                <li id="142">


                                    <a id="bibliography_8" title="Freed JK, Beyer AM, Logiudice JA, et al.Ceramide changes the mediator flow-induced vasodilation from nitric oxide to hydrogen peroxide in the human microcirculation[J].Cire Res, 2014, 115 (5) :525-532." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Ceramide changes the mediator of flow-induced vasodilation from nitric oxide to hydrogen peroxide in the human microcirculation">
                                        <b>[8]</b>
                                        Freed JK, Beyer AM, Logiudice JA, et al.Ceramide changes the mediator flow-induced vasodilation from nitric oxide to hydrogen peroxide in the human microcirculation[J].Cire Res, 2014, 115 (5) :525-532.
                                    </a>
                                </li>
                                <li id="144">


                                    <a id="bibliography_9" title="Evora PR, Evora PM, Celotto AC, et al.Cardiovascular therapeutics targets on the NO-sGC-cGMP signaling pathway:a critical overview[J].Curr Drug Targets, 2012, 13 (9) :1207-1214." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Cardiovascular Therapeutics Targets on the NO-sGC-cGMP Signaling Pathway: A Critical Overview">
                                        <b>[9]</b>
                                        Evora PR, Evora PM, Celotto AC, et al.Cardiovascular therapeutics targets on the NO-sGC-cGMP signaling pathway:a critical overview[J].Curr Drug Targets, 2012, 13 (9) :1207-1214.
                                    </a>
                                </li>
                                <li id="146">


                                    <a id="bibliography_10" title="Marcus ML, Chilian WM, Kanatsuka H, et al.Understanging the coronary circulation through studies at the microvascilar level[J].Circulation, 1990, 82 (1) :1-7." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK12103000014574&amp;v=MTc1MDBvQk1UNlQ0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRjBUYVJzPU5pZmNaYks2SDlIUHI0OUZaT29MQ1hzOQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[10]</b>
                                        Marcus ML, Chilian WM, Kanatsuka H, et al.Understanging the coronary circulation through studies at the microvascilar level[J].Circulation, 1990, 82 (1) :1-7.
                                    </a>
                                </li>
                                <li id="148">


                                    <a id="bibliography_11" title="Porto I, Belloni F, Niccoli G, et al.Filter no-reflow during percutaneous coronary intervention of saphenous vein grafts:incidence, predictictors and effect of the type of protection device[J].EuroIntervention, 2011, 7 (8) :955-961." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Filter no-reflow during percutaneous coronary intervention of saphenous vein grafts: incidence, predictors and effect of the type of protection device">
                                        <b>[11]</b>
                                        Porto I, Belloni F, Niccoli G, et al.Filter no-reflow during percutaneous coronary intervention of saphenous vein grafts:incidence, predictictors and effect of the type of protection device[J].EuroIntervention, 2011, 7 (8) :955-961.
                                    </a>
                                </li>
                                <li id="150">


                                    <a id="bibliography_12" title="Corbalan R, Larrain G, Nazzal C, et al.Association of noninvasive markers of coronary artery reperfusion to assess microvascular obsteuction in patients with acute myocardial infarction treated with primary angioplasty[J].Am J Cardiol, 2001, 88 (4) :342-346." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13011702178665&amp;v=MDk0NTNpZk9mYks3SHRETnFJOUhaZXdIQ25vOG9CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGMFRhUnM9Tg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[12]</b>
                                        Corbalan R, Larrain G, Nazzal C, et al.Association of noninvasive markers of coronary artery reperfusion to assess microvascular obsteuction in patients with acute myocardial infarction treated with primary angioplasty[J].Am J Cardiol, 2001, 88 (4) :342-346.
                                    </a>
                                </li>
                                <li id="152">


                                    <a id="bibliography_13" title="Inoue K, Hamada M, Ohstuka T, et al.Myocardial microvascular abnormalities observed by intravenous myocardial contrast echocardiography in patients with hypertrophic cardiomyopathy[J].Am J Cardiol, 2004, 94 (1) :55-58." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13011702175472&amp;v=MDc2NThxUVRNbndaZVp0RmlubFVyZklJRjBUYVJzPU5pZk9mYks3SHRETnFJOUhaZXdLQ0hzN29CTVQ2VDRQUUgvaXJSZEdlcg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[13]</b>
                                        Inoue K, Hamada M, Ohstuka T, et al.Myocardial microvascular abnormalities observed by intravenous myocardial contrast echocardiography in patients with hypertrophic cardiomyopathy[J].Am J Cardiol, 2004, 94 (1) :55-58.
                                    </a>
                                </li>
                                <li id="154">


                                    <a id="bibliography_14" title="Cannon RO 3rd, Rosing DR, Maron BJ, et al.Myocardial ischaemia in patients with hypertrophic cardiomyopathy:contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures[J].Circulation, 1985, 71 (2) :234-243." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK12103000011888&amp;v=MzIzNDFycVFUTW53WmVadEZpbmxVcmZJSUYwVGFScz1OaWZjWmJLNkg5SFByNDlGWk9vT0JIUXhvQk1UNlQ0UFFIL2lyUmRHZQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[14]</b>
                                        Cannon RO 3rd, Rosing DR, Maron BJ, et al.Myocardial ischaemia in patients with hypertrophic cardiomyopathy:contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures[J].Circulation, 1985, 71 (2) :234-243.
                                    </a>
                                </li>
                                <li id="156">


                                    <a id="bibliography_15" title="Camini PG, d&#39;Amati G, Rimodi O.Coronary microvascular dysfunction:mechanisms and functional assessment[J].Nat Rev Cardiol, 2015, 12 (1) :48-62." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Coronary microvascular dysfunction:mechanisms and functional assessment">
                                        <b>[15]</b>
                                        Camini PG, d&#39;Amati G, Rimodi O.Coronary microvascular dysfunction:mechanisms and functional assessment[J].Nat Rev Cardiol, 2015, 12 (1) :48-62.
                                    </a>
                                </li>
                                <li id="158">


                                    <a id="bibliography_16" title="Dean J, Cruz SD, Mehta PK, et al.Coronary microvascular dysfunction:sex-specific risk, diagnosis, and therapy[J].Nat Rev Cardiol, 2015, 12 (7) :406-414." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Coronary microvascular dysfunction:sex-specific risk,diagnosis,and therapy">
                                        <b>[16]</b>
                                        Dean J, Cruz SD, Mehta PK, et al.Coronary microvascular dysfunction:sex-specific risk, diagnosis, and therapy[J].Nat Rev Cardiol, 2015, 12 (7) :406-414.
                                    </a>
                                </li>
                                <li id="160">


                                    <a id="bibliography_17" title="Titterington JS, Hung OY, Wenger N.Microvascular angina:an update on diagnosis and treatment[J].Future Cardiol, 2015, 11 (2) :229-242." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJFS&amp;filename=SJFS15031200000001&amp;v=MjY3ODhhUnM9TmlmTmZiSzlIdExOclk5RlpPc1BESHc0b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUYwVA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[17]</b>
                                        Titterington JS, Hung OY, Wenger N.Microvascular angina:an update on diagnosis and treatment[J].Future Cardiol, 2015, 11 (2) :229-242.
                                    </a>
                                </li>
                                <li id="162">


                                    <a id="bibliography_18" title="Miller WL, Behrenbeck TR, McCollough CH, et al.Coronary microcirculation changes in non-ischemic dilated cardiomyopathy identifired by novel perfusion CT[J].Int J Cardiovasc Imaging, 2015, 31:881-888." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Coronary microcirculation changes in non-ischemic dilated cardiomyopathy identified by novel perfusion CT">
                                        <b>[18]</b>
                                        Miller WL, Behrenbeck TR, McCollough CH, et al.Coronary microcirculation changes in non-ischemic dilated cardiomyopathy identifired by novel perfusion CT[J].Int J Cardiovasc Imaging, 2015, 31:881-888.
                                    </a>
                                </li>
                                <li id="164">


                                    <a id="bibliography_19" title="Larose E, Rodes-Cabau J, Pibarot P, et al.Predicting late myocardial recovery and outcomes in the earaditional measures compared with microvascular obstruction, salvaged myocardium, and necrosid characteristics by cardiovas[J].J Am Coll Cardiol, 2010, 55 (22) :2459-2469." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012100337166&amp;v=MzIyNDRybzlGWitnSURYby9vQk1UNlQ0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRjBUYVJzPU5pZk9mYks3SHRETw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[19]</b>
                                        Larose E, Rodes-Cabau J, Pibarot P, et al.Predicting late myocardial recovery and outcomes in the earaditional measures compared with microvascular obstruction, salvaged myocardium, and necrosid characteristics by cardiovas[J].J Am Coll Cardiol, 2010, 55 (22) :2459-2469.
                                    </a>
                                </li>
                                <li id="166">


                                    <a id="bibliography_20" title="Coelho-Filho OR, Richers C, Kwong RY, et al.MR myocardial perfusion imaging[J].Radiol, 2013, 266 (3) :701-715." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=MR Myocardial Perfusion Imaging">
                                        <b>[20]</b>
                                        Coelho-Filho OR, Richers C, Kwong RY, et al.MR myocardial perfusion imaging[J].Radiol, 2013, 266 (3) :701-715.
                                    </a>
                                </li>
                                <li id="168">


                                    <a id="bibliography_21" title="Fearon WF, Low AF, Yong AS, et al.Prognostic value of the index of Microcirculatory Resistance measured after primary percutaneous coronary intervention [J].Circulation, 2013, 127 (24) :2436-2441." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK13071100003179&amp;v=MDcyOTJaT3NNRFhzd29CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGMFRhUnM9TmlmY1piSzdIdGJOcm85Rg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[21]</b>
                                        Fearon WF, Low AF, Yong AS, et al.Prognostic value of the index of Microcirculatory Resistance measured after primary percutaneous coronary intervention [J].Circulation, 2013, 127 (24) :2436-2441.
                                    </a>
                                </li>
                                <li id="170">


                                    <a id="bibliography_22" title="Ng MK, Yong AS, Ho M, et al, The index of microcirculatory resistance predicts myocardial infarction related topercutaneouscoronary intervention[J].Circ Cardiovasc Interv, 2012, 5 (4) :515-522." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK12110200001583&amp;v=MjE0ODFGMFRhUnM9TmlmY1piSzZIOURNclk5RlpPc09DWFE2b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[22]</b>
                                        Ng MK, Yong AS, Ho M, et al, The index of microcirculatory resistance predicts myocardial infarction related topercutaneouscoronary intervention[J].Circ Cardiovasc Interv, 2012, 5 (4) :515-522.
                                    </a>
                                </li>
                                <li id="172">


                                    <a id="bibliography_23" title="Lee BK, Yong AC, Fearon WF, et al.Invasive evalution of chest pain in patients with angiographically normal coronary arteries[J].Circulation, 2013, 128:A19113." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Invasive evaluation of chest pain in patients with angiographically normal coronary arteries">
                                        <b>[23]</b>
                                        Lee BK, Yong AC, Fearon WF, et al.Invasive evalution of chest pain in patients with angiographically normal coronary arteries[J].Circulation, 2013, 128:A19113.
                                    </a>
                                </li>
                                <li id="174">


                                    <a id="bibliography_24" title="Loffler AI, Bourque JM.Coronary microvascular dysfunction, microvascular angina, and management[J].Curr Cardiol Rep, 2016, 18 (1) :1-7." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Coronary microvascular dysfunction,microvascular angina,and management">
                                        <b>[24]</b>
                                        Loffler AI, Bourque JM.Coronary microvascular dysfunction, microvascular angina, and management[J].Curr Cardiol Rep, 2016, 18 (1) :1-7.
                                    </a>
                                </li>
                                <li id="176">


                                    <a id="bibliography_25" title="Yamabe H, Namura H, Yano T, et al.Effect of nicorandil on abnormal coronary flow reserve assessed by exercise 201 (TI) scintigraphy in patients with angina pectoris and nearly coronary arteriograms[J].Cardiovasc Drugs Ther, 1995, 9 (6) :755-761." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SSJD&amp;filename=SSJD00001063533&amp;v=MTA1NjNCYXJPNEh0SE5yNGxHWWVnTVkzazV6QmRoNGo5OVNYcVJyeG94Y01IN1I3cWRaK1p1RmlEbFU3elBJMWM9Tmo3&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[25]</b>
                                        Yamabe H, Namura H, Yano T, et al.Effect of nicorandil on abnormal coronary flow reserve assessed by exercise 201 (TI) scintigraphy in patients with angina pectoris and nearly coronary arteriograms[J].Cardiovasc Drugs Ther, 1995, 9 (6) :755-761.
                                    </a>
                                </li>
                                <li id="178">


                                    <a id="bibliography_26" title="Kostic J, Diordjevic-Dikic A, Dobric M, et al.The effects of nicorandil on microvascular function in patients with ST segment elevation myocardial infarction undergoing primary PCI[J].Cardiovasc Ultrasound, 2015, 13:26." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=The effects of nicorandil on microvascular function in patients with ST segment elevation myocardial infarction undergoing primary PCI">
                                        <b>[26]</b>
                                        Kostic J, Diordjevic-Dikic A, Dobric M, et al.The effects of nicorandil on microvascular function in patients with ST segment elevation myocardial infarction undergoing primary PCI[J].Cardiovasc Ultrasound, 2015, 13:26.
                                    </a>
                                </li>
                                <li id="180">


                                    <a id="bibliography_27" title="Tagliamonte E, Rigo F, Cirillo T, et al.Effects of ranolazine on nonivasive coronary flow reserve in patients with myocardial ischemia but without obstructive coronary artery disease[J].Echocardiography, 2015, 32 (3) :516-521." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWD15030400005085&amp;v=MjI1OThROG9CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGMFRhUnM9TmlmY2FySzlIdExNcTQ5RlpPc0tESA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[27]</b>
                                        Tagliamonte E, Rigo F, Cirillo T, et al.Effects of ranolazine on nonivasive coronary flow reserve in patients with myocardial ischemia but without obstructive coronary artery disease[J].Echocardiography, 2015, 32 (3) :516-521.
                                    </a>
                                </li>
                                <li id="182">


                                    <a id="bibliography_28" title="Villano A, Di Franco A, Nerla R, et al.Effects of ivabradine and ranolazine in petients with microvascular angina pectoris[J].Am J Cardiol, 2013, 112 (1) :8-13" target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13080200177207&amp;v=MDYyMDNGWmV3SURudytvQk1UNlQ0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRjBUYVJzPU5pZk9mYks3SHRuTXJZOQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[28]</b>
                                        Villano A, Di Franco A, Nerla R, et al.Effects of ivabradine and ranolazine in petients with microvascular angina pectoris[J].Am J Cardiol, 2013, 112 (1) :8-13
                                    </a>
                                </li>
                                <li id="184">


                                    <a id="bibliography_29" title="Porro B, Eligini S, Veglia F, et al.Nitric oxide synthetic pathway in patients with microvascular angina and its relations with oxidative stress[J].Oxid Med Cell Longev, 2014, 2014:726539." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJHD&amp;filename=SJHD14051200000444&amp;v=MDg5MTNySzhIdFROclk5RlpPc1BDSGc5b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUYwVGFScz1OaWZEYQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[29]</b>
                                        Porro B, Eligini S, Veglia F, et al.Nitric oxide synthetic pathway in patients with microvascular angina and its relations with oxidative stress[J].Oxid Med Cell Longev, 2014, 2014:726539.
                                    </a>
                                </li>
                                <li id="186">


                                    <a id="bibliography_30" title="徐辽杭, 卢亮.曲美他嗪治疗心脏X综合征疗效观察[J].全科医学临床与教育, 2013, 11 (1) :69-70" target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=QKYL201301026&amp;v=MjAzMTZxQnRHRnJDVVI3cWZadVptRnlqbVZMekJOQ2JTWXJHNEg5TE1ybzlIWW9RS0RIODR2UjRUNmo1NE8zenE=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[30]</b>
                                        徐辽杭, 卢亮.曲美他嗪治疗心脏X综合征疗效观察[J].全科医学临床与教育, 2013, 11 (1) :69-70
                                    </a>
                                </li>
                            </ul>
                            <div style='display: none;' class="zqscroller" >
                                <h4 class="">附加材料</h4>
                                <ul></ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            &nbsp;
            <!--此处有一空格符 勿删-->
        </div>

        
    <div class="content">



        <!--tips start-->
                            <div class="tips">
                    <a href="http://navi.cnki.net/KNavi/JournalDetail?pcode=CJFD&amp;pykm=XXGK" target="_blank">心血管康复医学杂志</a>
                2019,28(02),247-251 DOI:10.3969/j.issn.1008-0074.2019.02.30            </div>
        <!--tips end-->
            <div class="top-title">
                <h1 class="title">
                    <span class="vm"><b>冠状动脉微循环功能障碍研究新进展</b></span>
                                    </h1>

            </div>
                        <h2>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E8%82%96%E6%96%87%E9%A2%96&amp;code=25553644&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">肖文颖</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E9%BB%84%E7%BA%A2%E6%BC%AB&amp;code=08627986&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">黄红漫</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%86%AF%E5%85%AD%E5%85%AD&amp;code=08597990&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">冯六六</a>
                </h2>
                    <h2>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E4%B8%8A%E6%B5%B7%E6%9D%A8%E6%B5%A6%E5%8C%BA%E5%B8%82%E4%B8%9C%E5%8C%BB%E9%99%A2%E5%BF%83%E5%86%85%E7%A7%91&amp;code=0066716&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">上海杨浦区市东医院心内科</a>
            </h2>

        
<div class="link">
    <a id="aexport" class="icon icon-output"  onclick="" href="javascript:void(0);"><i></i>导出/参考文献</a>
    
    <span class="shareBoard" onmouseover="$('#sharedet').show();$('#this').addClass('shareBoardCUR')" onmouseout="$('#sharedet').hide();$('#this').removeClass('shareBoardCUR')">
        <a class="icon icon-share" href="#"><i></i>分享<em></em></a>
        <ul class="shareHide" id="sharedet" style="display: none;">
            <li><a title="复制链接" class="copy" onclick="" href="#"><i></i>复制链接</a></li>
            <li><a title="分享到新浪微博" class="xl" onclick="" href="javascript:common.ShareAction('xl');"><i></i>新浪微博</a></li>
            <li>
                <a title="分享到微信" class="wx" onclick="" href="#"><i></i>微信扫一扫</a>
                <div class="qrcode"><img src='' alt='' /></div>
            </li>
        </ul>

    </span>
    
    <a id="RefTrack" title="创建引文跟踪" class="icon icon-track" onclick="" href="javascript:void(0);"> <i></i>创建引文跟踪 </a>
    <a id="ashoucang" title="收藏" class="icon icon-favor" onclick="" href="javascript:void(0);"><i></i>收藏</a>
    <a class="icon icon-print" onclick="window.print();" href="javascript:void(0);"><i></i>打印</a>
    
    <!--版本切换 end-->
</div>
                            <div class="data" id="a_abstract">
                <span class="keys">摘<span style="font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;</span>要：</span>
                <p>冠状动脉微循环通过收缩和舒张功能调节冠脉血流量, 影响心肌灌注, 对于冠心病和心肌病患者的预后有着深远影响。随着近期无创和有创技术的发展, 药物治疗领域不断更新, 对于冠状动脉微循环功能障碍的认识也不断深入。本文就冠脉微循环功能障碍的新进展做如下综述。</p>
            </div>
                    <div class="data" id="a_keywords">
                <span class="keys">关键词：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%86%A0%E7%8A%B6%E5%8A%A8%E8%84%89%E5%BE%AA%E7%8E%AF&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">冠状动脉循环;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%BE%AE%E5%BE%AA%E7%8E%AF&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">微循环;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%86%A0%E7%8A%B6%E5%8A%A8%E8%84%89%E7%96%BE%E7%97%85&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">冠状动脉疾病;</a>
                </p>
            </div>
        
        <!--brief start-->
        
            <div class="brief">
                    <p>
                            <b>作者简介：</b>
                                                        <span>
                                    *黄红漫, E-mail:huanghongman11@163.com;
                                </span>
                    </p>
                                    <p><b>收稿日期：</b>2017-12-07</p>

                    <p>

                            <b>基金：</b>
                                                        <span>上海市卫生和计划生育委员会科研课题 (201540298);</span>
                    </p>
            </div>
                    <h1>New research progress of coronary microvascular dysfunction</h1>
                    <h2>
                    <span>XIAO Wen-ying</span>
                    <span>HUANG Hong-man</span>
                    <span>FENG Liu-liu</span>
            </h2>
                    <h2>
                    <span>Department of Cardiology, Shidong Hospital of Yangpu District, Shanghai</span>
            </h2>
                            <div class="data" id="a_abstractEN">
                <span class="keys">Abstract：</span>
                <p>Coronary microcirculation regulates coronary blood flow volume via systolic and diastolic function and affects myocardial perfusion, which possesses deep influence on prognosis of patients with coronary heart disease and cardiomyopathy. Along with developments of recent noninvasive and invasive techniques, continuous updates of medication area, understanding of coronary microvascular dysfunction keeps going deeper. The present article made following review on new research progress of coronary microvascular dysfunction.</p>
            </div>
                    <div class="data" id="a_keywordsEN">
                <span class="keys">Keyword：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Coronary%20circulation&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Coronary circulation;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Microcirculation&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Microcirculation;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Coronary%20artery%20disease&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Coronary artery disease;</a>
                </p>
            </div>
                    <div class="brief">
                
                    <p>
                            <b>Author：</b>
                                                        <span>
                                    HUANG Hong-man, E-mail:huanghongman11@163.com;
                                </span>
                    </p>
                                    <p><b>Received：</b> 2017-12-07</p>
                                    <p>
                            <b>Fund：</b>
                                                        <span>Shanghai Health and Family Planning Commission Research Project (201540298);</span>
                    </p>
            </div>


        <!--brief start-->
                        <div class="p1">
                    <p id="63">冠状动脉系统是由三个功能不同的部分组成, 包括:心外膜大血管, 中间部分的前小动脉, 远端部分的微小动脉。心外膜大动脉的直径从500μm到几毫米, 冠状动脉造影可显示。前小动脉直径为100～500μm, 微小动脉直径小于100μm。其中前小动脉和微小动脉在冠状动脉造影中不能显影。</p>
                </div>
                <div class="p1">
                    <p id="64">冠状动脉微血管在心肌血供中起重要作用, 其调节机制相当复杂, 这种调节机制的异常通常被称为冠状动脉微血管功能障碍 (Coronary Microvascular Dysfunction, CMD) 。因其不能在冠脉造影中显影, 导致临床工作中容易被忽视。许多研究证实冠状动脉微循环在调节冠状动脉血流量及心肌灌注中发挥重要作用<citation id="188" type="reference"><link href="128" rel="bibliography" /><sup>[<a class="sup">1</a>]</sup></citation>。因此, 我们在注重心外膜大血管冠状动脉病变防治的同时, 对于冠状动脉微血管功能障碍亦应引起足够重视, 且这部分人群不占少数。</p>
                </div>
                <h3 id="65" name="65" class="anchor-tag"><b>1 冠状动脉微血管功能障碍的分型和临床特点</b></h3>
                <div class="p1">
                    <p id="66">Camini<citation id="189" type="reference"><link href="130" rel="bibliography" /><sup>[<a class="sup">2</a>]</sup></citation>和Crea提出CMD按其发生的临床基础分为四种类型。</p>
                </div>
                <div class="p1">
                    <p id="67"> (1) 无心肌疾病和阻塞性冠状动脉疾病的CMD:冠状动脉危险因素 (吸烟, 高血压, 高脂血症, 糖尿病和胰岛素抵抗) , 该类型至少部分可逆; (2) 心肌疾病的CMD:存在微小动脉的负性重构, 多见于原发性心肌病[扩张性心肌病 (DCM) 、肥厚性心肌病 (HCM) ]和继发性心肌病 (高血压和心脏瓣膜病) 也可见于应激性心肌病; (3) 阻塞性冠状动脉疾病 (CAD) 的CMD:见于稳定型CAD, ST抬高型心肌梗死 (STEMI) , 非ST抬高型心肌梗死 (NSTEMI) , 较难识别, 受多种因素影响; (4) 医源性CMD:发生在冠状动脉再灌注治疗后, 主要是由原发性血管收缩和远端栓塞引起 (在经皮冠脉介入治疗后仍然存在心绞痛患者中, 20%可能与CMD有关<citation id="190" type="reference"><link href="132" rel="bibliography" /><sup>[<a class="sup">3</a>]</sup></citation>) , 冠状动脉最大血流与静息血流的比值 (CFR) 可在血运重建后数周内自行恢复。其中无心肌疾病和阻塞性冠状动脉疾病的CMD包括几种特殊类型, 需引起重视。</p>
                </div>
                <h4 class="anchor-tag" id="68" name="68">1.1 原发性稳定型微血管性心绞痛 (MVA) </h4>
                <div class="p1">
                    <p id="69">MVA的定义是指劳力相关的心绞痛, 并且无阻塞性CAD, 心肌疾病和任何其他明显的心血管疾病。CMD是导致心肌缺血和胸痛的主要原因。此类心绞痛病因复杂多样, 包括传统的危险因素 (高血压, 高胆固醇血症, 血糖异常, 吸烟) 和雌激素缺乏, 胰岛素敏感性降低, 炎症刺激, 肾上腺素能活动增加等等。这类患者常见表现为运动应激时短暂性心电图ST段压低, 也包括药物负荷诱发, 或动态心电图记录的ST段压低。50%～60%的MVA患者负荷心肌灌注成像可以发现可逆的充盈缺损<citation id="191" type="reference"><link href="134" rel="bibliography" /><link href="136" rel="bibliography" /><sup>[<a class="sup">4</a>,<a class="sup">5</a>]</sup></citation>。研究表明, 部分MVA患者对于通常看来微弱的心脏刺激的痛觉感知增强, 所以MVA患者的症状取决于CMD的程度和对疼痛感的耐受程度。MVA较阻塞性CAD胸痛比, 常表现为胸痛持续至运动停止后几分钟, 或对短效硝酸酯类药物起效缓慢或无效。其次, 运动负荷试验时患者对舌下含服硝酸甘油反应情况也可以与CAD患者鉴别, MVA患者含服硝酸甘油后症状无改善, 甚至可能恶化。此类患者确诊需依靠应用血管扩张剂和血管收缩剂时冠状动脉微循环情况的评估来诊断。稳定型MVA患者首选血管扩张试验, 如果结果正常或不能确定, 再进一步行血管收缩刺激药物进行评估。临床上常用无创经胸多普勒超声心动图 (TTDE) 记录冠状动脉血流 (CBF) 速度来检测[主要针对左前降支 (LAD) ]。CFR小于2.0可以确诊CMD。队列研究显示以典型原发性稳定型MVA为特点的患者通常预后良好<citation id="192" type="reference"><link href="138" rel="bibliography" /><link href="140" rel="bibliography" /><sup>[<a class="sup">6</a>,<a class="sup">7</a>]</sup></citation>。</p>
                </div>
                <h4 class="anchor-tag" id="70" name="70">1.2 原发性急性微血管性心绞痛</h4>
                <div class="p1">
                    <p id="71">5%～10%的有典型急性胸痛症状的患者, 其症状表现为NSTECS, 但冠脉造影正常, 女性多见, 胸痛常出现在静息时或轻微活动后。其可能的机制为CMD, 一过性血栓或栓塞形成, 心外膜冠状动脉痉挛和心肌炎。从冠状动脉微循环的角度去解释急性胸痛, 可能是由于微血管的过度收缩导致。机制有待进一步研究。该诊断需要通过有创的检查去支持, 且需除外其他三种原因才能确诊。对于这部分患者的预后, 目前的临床研究得出的结果各有分歧, 有待进一步探讨。</p>
                </div>
                <div class="p1">
                    <p id="72">冠状动脉微血管功能障碍的发病机制大体上可分三种, 见表1<citation id="193" type="reference"><link href="130" rel="bibliography" /><sup>[<a class="sup">2</a>]</sup></citation>。这些机制在不同临床条件下有所不同, 但在同一情况下他们可能并存<citation id="194" type="reference"><link href="130" rel="bibliography" /><sup>[<a class="sup">2</a>]</sup></citation>。</p>
                </div>
                <div class="area_img" id="73">
                    <p class="img_tit"><b>表</b>1 <b>冠状动脉微血管功能障碍的发病机制</b> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="73" border="1"><tr><td><br /></td><td>变化</td><td>病因</td></tr><tr><td><br />结构性</td><td>管腔阻塞</td><td>ACS或者血管再通后微血栓</td></tr><tr><td><br /></td><td>管壁通透性</td><td>浸润性心肌病 (如Anderson-Fabry 心肌病) </td></tr><tr><td><br /></td><td>血管重构</td><td>HCM, 高血压</td></tr><tr><td><br /></td><td>血管减少</td><td>主动脉瓣狭窄, 高血压</td></tr><tr><td><br /></td><td>血管周围纤维化</td><td>主动脉瓣狭窄, 高血压</td></tr><tr><td><br />功能性</td><td>内皮功能障碍</td><td>吸烟, 高脂血症, 糖尿病</td></tr><tr><td><br /></td><td>平滑肌细胞功能障碍</td><td>HCM, 高血压</td></tr><tr><td><br /></td><td>自主神经功能障碍</td><td>冠状动脉血管再通</td></tr><tr><td><br />血管外</td><td>血管外的压迫</td><td>主动脉瓣狭窄, HCM, 高血压</td></tr><tr><td><br /></td><td>舒张期灌注时间缩短</td><td>主动脉瓣狭窄</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:ACS:急性冠脉综合征, HCM:肥厚性心肌病。</p>
                    <p class="img_note"></p>
                </div>
                <h3 id="74" name="74" class="anchor-tag">2.1 结构性机制</h3>
                <div class="p1">
                    <p id="75">结构改变引起CMD常见于HCM和高血压患者。这两种疾病的主要结构变化特点是微小冠脉腔内负性重构, 包括血管平滑肌肥大导致的管壁增厚和中膜胶原沉积伴有不同程度的内膜增厚, 进而导致管腔变窄, 微小冠脉阻力增加, CFR下降<citation id="195" type="reference"><link href="130" rel="bibliography" /><sup>[<a class="sup">2</a>]</sup></citation>。除此之外, 结构改变还包括中膜增生肥大, 心内膜增殖和退化, 内皮细胞增殖, 毛细血管床稀疏等。</p>
                </div>
                <h3 id="76" name="76" class="anchor-tag">2.2 功能性机制</h3>
                <h4 class="anchor-tag" id="122" name="122">2.2.1 内皮依赖的血管舒张改变:</h4>
                <div class="p1">
                    <p id="77">血管内皮功能下降会引起冠脉微循环功能障碍<citation id="196" type="reference"><link href="142" rel="bibliography" /><sup>[<a class="sup">8</a>]</sup></citation>。NO的产生和释放是内皮依赖性血管舒张的最重要机制, 内皮功能障碍时它最先发生异常。研究发现NO合成酶的活性降低, 血清A非对称性二甲基精氨酸 (DMD) 水平增加都会导致NO生成受损, 而过氧化物离子 (包括糖尿病, 肥胖, 吸烟等) 的增加则会导致NO降解增加。除此之外, 在某些情况下, NO依赖的血管舒张功能受损可能与平滑肌细胞对正常水平NO反应性改变有关<citation id="197" type="reference"><link href="144" rel="bibliography" /><sup>[<a class="sup">9</a>]</sup></citation>。由于NO的半衰期很短, 临床上识别内皮依赖性冠状动脉微血管异常主要基于冠脉血流的减少和冠脉对内皮细胞释放NO的扩血管作用反应的下降。冷加压试验是一种检测微循环血液灌流量 (MBF) 的无创影像学技术, 也是评价内皮依赖性CMD的有效方法。</p>
                </div>
                <h4 class="anchor-tag" id="123" name="123">2.2.2 非内皮依赖血管舒张改变:</h4>
                <div class="p1">
                    <p id="78">尽管多个临床观察证实非内皮依赖的血管舒张受损能导致CMD, 但其细胞机制仍不完全明确。我们知道, 受损的血管平滑肌细胞对血管舒张药物的反应性减低, 具有自主调节和反应性充血的功能, 使血流介导的扩张受损<citation id="198" type="reference"><link href="146" rel="bibliography" /><sup>[<a class="sup">10</a>]</sup></citation>。目前已知两种细胞内通路导致平滑肌细胞松弛。一个是腺苷酸环化酶的激活, 产生环-磷酸腺苷 (cAMP) 进而抑制钙离子进入平滑肌, 另一条是依赖腺苷三磷酸环化酶的激活, 产生环磷鸟苷 (cGMP) 。</p>
                </div>
                <h4 class="anchor-tag" id="124" name="124">2.2.3 血管收缩:</h4>
                <div class="p1">
                    <p id="79">冠状动脉微循环血管收缩增强与血管收缩受体激动剂释放增加或者平滑肌细胞对血管收缩的刺激敏感性增加有关。研究发现, 微血管收缩异常常见于稳定型心绞痛, 心肌炎, 应激性心肌病, PCI术后胸痛患者等等。</p>
                </div>
                <h4 class="anchor-tag" id="125" name="125">2.2.4 血管内阻塞:</h4>
                <div class="p1">
                    <p id="80">由于血管内阻塞导致的CMD常见于缺血-再灌注相关事件。阻塞的物质可由粥样斑块碎屑, 微血栓和中性粒细胞-血小板聚集导致。粥样斑块碎屑, 微血栓引起的血管堵塞, 常见于PCI术中冠状动脉不稳定斑块的操作, 特别是退化的大隐静脉桥血管<citation id="199" type="reference"><link href="148" rel="bibliography" /><sup>[<a class="sup">11</a>]</sup></citation>。在此情况下, 可检查到心肌坏死标志物升高, 它较没有坏死标志物升高的PCI预后差<citation id="200" type="reference"><link href="150" rel="bibliography" /><sup>[<a class="sup">12</a>]</sup></citation>。</p>
                </div>
                <h3 id="81" name="81" class="anchor-tag">2.3 血管外机制</h3>
                <h4 class="anchor-tag" id="126" name="126">2.3.1 管腔外压力:</h4>
                <div class="p1">
                    <p id="82">众所周知, 冠状动脉血流受到收缩期和舒张期心肌内和心室内压力变化的影响, 其中主要是舒张期。然而, 对于原发性和继发性高血压患者, 收缩期心肌内和心室压力增加会对心肌灌注造成不利影响<citation id="201" type="reference"><link href="152" rel="bibliography" /><sup>[<a class="sup">13</a>]</sup></citation>。收缩期微血管压力增加使得心内膜下血管在舒张期不能恢复到基础状态, 影响心内膜下微血管的舒张期冠脉动脉血流<citation id="202" type="reference"><link href="154" rel="bibliography" /><sup>[<a class="sup">14</a>]</sup></citation>。</p>
                </div>
                <h4 class="anchor-tag" id="127" name="127">2.3.2 舒张时间缩短:</h4>
                <div class="p1">
                    <p id="83">因为冠状动脉血流主要在舒张期, 舒张期时间缩短可引起心肌灌注明显减少, 比如主动脉瓣狭窄, 冠状动脉临界狭窄, 小动脉收缩或低血压状态。并且由于舒张时间减少对心肌灌注的不利影响, 在心内膜中要比心外膜中更加明显, 从而加重了冠脉微循环功能障碍。</p>
                </div>
                <h3 id="84" name="84" class="anchor-tag"><b>3 冠状动脉微循环的评估方法</b></h3>
                <div class="p1">
                    <p id="85">由于CMD患者体格检查多无异常, 近年来对冠脉微血管功能的评估进行了大量研究<citation id="203" type="reference"><link href="128" rel="bibliography" /><link href="156" rel="bibliography" /><link href="158" rel="bibliography" /><link href="160" rel="bibliography" /><sup>[<a class="sup">1</a>,<a class="sup">15</a>,<a class="sup">16</a>,<a class="sup">17</a>]</sup></citation>, 总体来看, 分为无创和有创两大类 (见表2, 表3) 。</p>
                </div>
                <div class="area_img" id="86">
                                            <p class="img_tit">
                                                <b>表</b>2 <b>冠状动脉微循环的无创评估方法</b>
                                                
                                                &nbsp;&nbsp;
                                                <a class="btn-zoomin" href="Detail/GetImg?filename=images/XXGK201902030_08600.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!"></a>
                                                <a class="table downimg" data-tablename="Detail/GetImg?filename=images/XXGK201902030_08600.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">下载原表</a>
                                            </p>
                                    <a class="zoom-in" href="Detail/GetImg?filename=images/XXGK201902030_08600.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <img alt="表2 冠状动脉微循环的无创评估方法" src="Detail/GetImg?filename=images/XXGK201902030_08600.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
                                    </a>

                </div>
                <div class="area_img" id="87">
                                            <p class="img_tit">
                                                <b>表</b>3 <b>冠状动脉微循环障碍有创评估方法</b>
                                                
                                                &nbsp;&nbsp;
                                                <a class="btn-zoomin" href="Detail/GetImg?filename=images/XXGK201902030_08700.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!"></a>
                                                <a class="table downimg" data-tablename="Detail/GetImg?filename=images/XXGK201902030_08700.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">下载原表</a>
                                            </p>
                                    <a class="zoom-in" href="Detail/GetImg?filename=images/XXGK201902030_08700.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <img alt="表3 冠状动脉微循环障碍有创评估方法" src="Detail/GetImg?filename=images/XXGK201902030_08700.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
                                    </a>

                </div>
                <h3 id="88" name="88" class="anchor-tag"><b>4 冠状动脉微循环功能障碍的治疗</b></h3>
                <div class="p1">
                    <p id="89">在过去的几十年里, 对于冠状动脉微循环功能障碍的治疗, 大体上分为两大类, 药物治疗和非药物治疗。非药物治疗包括:脊髓刺激, 经皮神经电刺激, 增强型体外反博, 以及心血管运动康复和心理干预。前三种器械治疗, 虽在小样本的研究中获得了一定的成果, 但仍需要较大规模的随机对照研究去验证。心血管康复治疗和心理干预治疗往往被用于难治性微血管性心绞痛患者。因此, 对于CMD患者来说, 最主要的还是药物治疗。以下是临床已证实有效的相关药物。</p>
                </div>
                <div class="p1">
                    <p id="90"> (1) β受体阻滞剂:这类药物可降低心肌耗氧量, 特别是在运动和应激状态期间, 也可通过延长舒张时间和改善左室运动力学改善冠脉动脉灌注。在β受体阻滞剂中, 有研究提示, 通过β3受体改善血管内皮功能的奈比洛尔和具有α受体阻断作用的卡维地洛对微血管功能障碍具有良好效果。</p>
                </div>
                <div class="p1">
                    <p id="91"> (2) 钙通道拮抗剂:此类药物中, 以非二氢吡啶类钙通道阻滞剂作为替代β受体阻滞剂的一线治疗。其机制主要是强效的扩血管作用和减轻心脏后负荷, 此外, 还可通过负性变时和负性肌力作用降低心肌耗氧量。</p>
                </div>
                <div class="p1">
                    <p id="92"> (3) 黄嘌呤衍生物:黄嘌呤在微血管性心绞痛的有益效果与两个不同的机制相关, 分别是对血管平滑肌细胞A2受体的拮抗以及刺激突触前A1受体, 最终有利于冠状动脉血流量 (CBF) 流向微血管功能失调的区域。此外, 黄嘌呤还具有“镇痛”效果, 能拮抗腺苷对心脏植物神经疼痛纤维的刺激, 提高患者的疼痛阈值<citation id="204" type="reference"><link href="174" rel="bibliography" /><sup>[<a class="sup">24</a>]</sup></citation>。</p>
                </div>
                <div class="p1">
                    <p id="93"> (4) 血管紧张素转换酶抑制剂:总体来看, 血管紧张素转换酶抑制剂和血管紧张素II受体阻滞剂显示出可以改善内皮依赖性冠状动脉微血管功能和使其正常化。</p>
                </div>
                <div class="p1">
                    <p id="94"> (5) 尼可地尔:尼克地尔作为腺苷三磷酸ATP钾通道开放剂, 具有硝酸盐样作用。它可以直接扩张冠状动脉阻力血管, 还可以调节这些血管对交感神经刺激的反应。在一项11例微血管性心绞痛患者的非对照研究中, 静脉应用尼可地尔能减轻运动诱发的心电图ST段压低范围和程度, 以及铊心肌显像中心肌灌注缺损的严重程度<citation id="205" type="reference"><link href="176" rel="bibliography" /><sup>[<a class="sup">25</a>]</sup></citation>。Kostic等小样本研究证实急诊PCI术后1d应用尼可地尔可改善微循环功能, 降低IMR, 增加冠状动脉血流储备, 3个月后心功能有所改善<citation id="206" type="reference"><link href="178" rel="bibliography" /><sup>[<a class="sup">26</a>]</sup></citation>。</p>
                </div>
                <div class="p1">
                    <p id="95"> (6) 雷诺嗪:雷诺嗪是一种抗缺血药物, 主要通过抑制晚期钠离子内流, 降低缺血心肌细胞内钙离子超载, 从而改善心肌松弛度和左室舒张功能<citation id="207" type="reference"><link href="180" rel="bibliography" /><sup>[<a class="sup">27</a>]</sup></citation>。在一项研究中, 45例微血管性心绞痛患者随机应用雷诺嗪, 伊伐布雷定或安慰剂治疗四周, 相比伊伐布雷定组和安慰剂组, 雷诺嗪改善心绞痛状态和运动负荷试验结果更为显著<citation id="208" type="reference"><link href="182" rel="bibliography" /><sup>[<a class="sup">28</a>]</sup></citation>。</p>
                </div>
                <div class="p1">
                    <p id="96"> (7) 他汀类药物:研究显示, MVA患者以微血管中的红细胞产生一氧化氮的能力受到损伤为特点<citation id="209" type="reference"><link href="184" rel="bibliography" /><sup>[<a class="sup">29</a>]</sup></citation>。他汀类药物可通过其强大的抗氧化和抗炎, 以及降低胆固醇的作用去改善血管内皮功能, 对CMD患者产生有利影响, 其中辛伐他汀, 普伐他汀, 阿托伐他汀均有相关临床研究证实。</p>
                </div>
                <div class="p1">
                    <p id="97"> (8) 一些具有争议的药物:①雌激素:稳定型微血管性心绞痛患者主要发生于围绝经期女性, 提示雌激素缺乏可能是一个重要的致病因子。对于那些具有雌激素缺乏临床证据的女性微血管性心绞痛的患者, 可以使用雌激素进行治疗, 但由于长期应用后一些不良临床事件的风险增加, 从而抵消早期的获益。所以并不常规推荐。②曲美他嗪:此药可通过切换细胞代谢模式而改善心肌缺血耐受性, 从游离脂肪酸氧化优先转化为葡萄糖氧化优先。对微血管性心绞痛患者, 临床研究结果并不一致。徐辽杭等在MVA常规治疗基础上加用曲美他嗪, 取得较好疗效<citation id="210" type="reference"><link href="186" rel="bibliography" /><sup>[<a class="sup">30</a>]</sup></citation>。③伊伐布雷定:伊伐布雷定通过抑制窦房结If电流, 抑制窦房结功能, 从而减慢心率。目前仅有非常少的研究关注其对微血管性心绞痛患者的作用, 其是否有效有待进一步探讨。</p>
                </div>
                <div class="p1">
                    <p id="98">综上所述, 冠状动脉微循环功能障碍无论是在各种类型的冠脉疾病还是心肌疾病的演变过程中均充当了非常重要的角色, 所以, 我们对于临床上胸痛患者的冠状动脉微循环评估势在必行。随着科学技术不断地发展, 相信会有更有效更精准的方法用于评估冠脉微循环功能障碍, 会有更多有效的方法去改善冠脉微循环功能障碍, 最终帮助临床医生去更全面地对此类患者进行诊断, 治疗和预后评估。</p>
                </div>

        <!--brief end-->
        
        <!--conten left  end-->
        <!--增强附件-->
        

        <!--reference start-->
            <div class="reference anchor-tag" id="a_bibliography">
                    <h3>参考文献</h3>
                                        <p id="128">
                            <a id="bibliography_1" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Coronary microvascular dysfunction:an update">

                                <b>[1]</b>Crea F, Camici PG, Bairey Merz CN.Coronary microvascular dysfunction:an update[J].Eur Heart J, 2014, 35 (17) :1101-1111.
                            </a>
                        </p>
                        <p id="130">
                            <a id="bibliography_2" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Coronary microvascular dysfunction">

                                <b>[2]</b>Camici PG, Crea F.Coronary microvascular dysfunction[J].N Engl J Med, 2007, 356 (8) :830-840.
                            </a>
                        </p>
                        <p id="132">
                            <a id="bibliography_3" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWDF81458BC15E3C0841E880681062EF078&amp;v=MDg2NTJhc1d3SDlYSnAvMDJaZTU2RHc4NXh4SVNuemQxU0hucXJSSXplOGZpUmIyWENPTnZGU2lXV3I3SklGcG1hQnVIWWZPR1FsZkJyTFUwNXRCaHhMdTR3NkU9TmlmYw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[3]</b>Suzuki H.Different definition of microvascular angina[J].Eur J Clin Incest, 2015, 45 (12) :1360-1366.
                            </a>
                        </p>
                        <p id="134">
                            <a id="bibliography_4" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Quantitative thallium imaging findings in patients with normal coronary angiographic findings and in clinically normal subjects">

                                <b>[4]</b>Kaul S, Newell JB, Chesler DA, et al.Quantitative thallium imaging fingings in patients with normal coronary angiographic findings and in clinically normal subjects[J].Am J Cardiol, 1986, 57 (8) :509-512.
                            </a>
                        </p>
                        <p id="136">
                            <a id="bibliography_5" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Regional distribution and extent of perfusion abnormalities, and the lung to heart uptake ratios during exercise thallium-201 SPECT imaging in patients with cardiac syndrome X">

                                <b>[5]</b>Cavusoglu Y, Entok E, Timuralp B, et al.Regional distribution and extent of perfusion abnormalities, and the lung to heart uptake ratios duing exercise thallium-201 SPECT imaging in petients with cardiac syndrome X[J].Can J Cardiol, 2005, 21 (1) :57-62.
                            </a>
                        </p>
                        <p id="138">
                            <a id="bibliography_6" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012300495105&amp;v=MTExMzBud1plWnRGaW5sVXJmSUlGMFRhUnM9TmlmT2ZiSzdIdERPckk5RllPSUtEWHc4b0JNVDZUNFBRSC9pclJkR2VycVFUTQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[6]</b>Lamendola P, Lanza GA, Spinelli A, et al.Long-term prognosis of patients with cardiac syndrome X[J].Int J Cardiol, 2010, 140 (2) :197-199.
                            </a>
                        </p>
                        <p id="140">
                            <a id="bibliography_7" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK12103000030716&amp;v=MTIyNjBDMzAvb0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUYwVGFScz1OaWZjWmJLNkg5SFByNDlGWk9nUA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[7]</b>Bugiardini R, Manfrini O, Pizzi C, et al.Endothelial function predicts future development of coronary artery disease:a study of women with chest pain and normal coronary angiograms[J].Circulation, 2004, 109 (21) :2518-2523.
                            </a>
                        </p>
                        <p id="142">
                            <a id="bibliography_8" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Ceramide changes the mediator of flow-induced vasodilation from nitric oxide to hydrogen peroxide in the human microcirculation">

                                <b>[8]</b>Freed JK, Beyer AM, Logiudice JA, et al.Ceramide changes the mediator flow-induced vasodilation from nitric oxide to hydrogen peroxide in the human microcirculation[J].Cire Res, 2014, 115 (5) :525-532.
                            </a>
                        </p>
                        <p id="144">
                            <a id="bibliography_9" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Cardiovascular Therapeutics Targets on the NO-sGC-cGMP Signaling Pathway: A Critical Overview">

                                <b>[9]</b>Evora PR, Evora PM, Celotto AC, et al.Cardiovascular therapeutics targets on the NO-sGC-cGMP signaling pathway:a critical overview[J].Curr Drug Targets, 2012, 13 (9) :1207-1214.
                            </a>
                        </p>
                        <p id="146">
                            <a id="bibliography_10" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK12103000014574&amp;v=MDQzNDJmSUlGMFRhUnM9TmlmY1piSzZIOUhQcjQ5RlpPb0xDWHM5b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[10]</b>Marcus ML, Chilian WM, Kanatsuka H, et al.Understanging the coronary circulation through studies at the microvascilar level[J].Circulation, 1990, 82 (1) :1-7.
                            </a>
                        </p>
                        <p id="148">
                            <a id="bibliography_11" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Filter no-reflow during percutaneous coronary intervention of saphenous vein grafts: incidence, predictors and effect of the type of protection device">

                                <b>[11]</b>Porto I, Belloni F, Niccoli G, et al.Filter no-reflow during percutaneous coronary intervention of saphenous vein grafts:incidence, predictictors and effect of the type of protection device[J].EuroIntervention, 2011, 7 (8) :955-961.
                            </a>
                        </p>
                        <p id="150">
                            <a id="bibliography_12" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13011702178665&amp;v=MjczMjVyZklJRjBUYVJzPU5pZk9mYks3SHRETnFJOUhaZXdIQ25vOG9CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[12]</b>Corbalan R, Larrain G, Nazzal C, et al.Association of noninvasive markers of coronary artery reperfusion to assess microvascular obsteuction in patients with acute myocardial infarction treated with primary angioplasty[J].Am J Cardiol, 2001, 88 (4) :342-346.
                            </a>
                        </p>
                        <p id="152">
                            <a id="bibliography_13" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13011702175472&amp;v=MjAxMzBmT2ZiSzdIdEROcUk5SFpld0tDSHM3b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUYwVGFScz1OaQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[13]</b>Inoue K, Hamada M, Ohstuka T, et al.Myocardial microvascular abnormalities observed by intravenous myocardial contrast echocardiography in patients with hypertrophic cardiomyopathy[J].Am J Cardiol, 2004, 94 (1) :55-58.
                            </a>
                        </p>
                        <p id="154">
                            <a id="bibliography_14" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK12103000011888&amp;v=MjIxOTVUNlQ0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRjBUYVJzPU5pZmNaYks2SDlIUHI0OUZaT29PQkhReG9CTQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[14]</b>Cannon RO 3rd, Rosing DR, Maron BJ, et al.Myocardial ischaemia in patients with hypertrophic cardiomyopathy:contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures[J].Circulation, 1985, 71 (2) :234-243.
                            </a>
                        </p>
                        <p id="156">
                            <a id="bibliography_15" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Coronary microvascular dysfunction:mechanisms and functional assessment">

                                <b>[15]</b>Camini PG, d'Amati G, Rimodi O.Coronary microvascular dysfunction:mechanisms and functional assessment[J].Nat Rev Cardiol, 2015, 12 (1) :48-62.
                            </a>
                        </p>
                        <p id="158">
                            <a id="bibliography_16" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Coronary microvascular dysfunction:sex-specific risk,diagnosis,and therapy">

                                <b>[16]</b>Dean J, Cruz SD, Mehta PK, et al.Coronary microvascular dysfunction:sex-specific risk, diagnosis, and therapy[J].Nat Rev Cardiol, 2015, 12 (7) :406-414.
                            </a>
                        </p>
                        <p id="160">
                            <a id="bibliography_17" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJFS&amp;filename=SJFS15031200000001&amp;v=MTk3MDFlWnRGaW5sVXJmSUlGMFRhUnM9TmlmTmZiSzlIdExOclk5RlpPc1BESHc0b0JNVDZUNFBRSC9pclJkR2VycVFUTW53Wg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[17]</b>Titterington JS, Hung OY, Wenger N.Microvascular angina:an update on diagnosis and treatment[J].Future Cardiol, 2015, 11 (2) :229-242.
                            </a>
                        </p>
                        <p id="162">
                            <a id="bibliography_18" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Coronary microcirculation changes in non-ischemic dilated cardiomyopathy identified by novel perfusion CT">

                                <b>[18]</b>Miller WL, Behrenbeck TR, McCollough CH, et al.Coronary microcirculation changes in non-ischemic dilated cardiomyopathy identifired by novel perfusion CT[J].Int J Cardiovasc Imaging, 2015, 31:881-888.
                            </a>
                        </p>
                        <p id="164">
                            <a id="bibliography_19" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13012100337166&amp;v=MDA0NTFRVE1ud1plWnRGaW5sVXJmSUlGMFRhUnM9TmlmT2ZiSzdIdERPcm85RlorZ0lEWG8vb0JNVDZUNFBRSC9pclJkR2VycQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[19]</b>Larose E, Rodes-Cabau J, Pibarot P, et al.Predicting late myocardial recovery and outcomes in the earaditional measures compared with microvascular obstruction, salvaged myocardium, and necrosid characteristics by cardiovas[J].J Am Coll Cardiol, 2010, 55 (22) :2459-2469.
                            </a>
                        </p>
                        <p id="166">
                            <a id="bibliography_20" target="_blank" href="http://scholar.cnki.net/result.aspx?q=MR Myocardial Perfusion Imaging">

                                <b>[20]</b>Coelho-Filho OR, Richers C, Kwong RY, et al.MR myocardial perfusion imaging[J].Radiol, 2013, 266 (3) :701-715.
                            </a>
                        </p>
                        <p id="168">
                            <a id="bibliography_21" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK13071100003179&amp;v=MDUwNjhyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRjBUYVJzPU5pZmNaYks3SHRiTnJvOUZaT3NNRFhzd29CTVQ2VDRQUUgvaQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[21]</b>Fearon WF, Low AF, Yong AS, et al.Prognostic value of the index of Microcirculatory Resistance measured after primary percutaneous coronary intervention [J].Circulation, 2013, 127 (24) :2436-2441.
                            </a>
                        </p>
                        <p id="170">
                            <a id="bibliography_22" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK12110200001583&amp;v=MDk5MjZzPU5pZmNaYks2SDlETXJZOUZaT3NPQ1hRNm9CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGMFRhUg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[22]</b>Ng MK, Yong AS, Ho M, et al, The index of microcirculatory resistance predicts myocardial infarction related topercutaneouscoronary intervention[J].Circ Cardiovasc Interv, 2012, 5 (4) :515-522.
                            </a>
                        </p>
                        <p id="172">
                            <a id="bibliography_23" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Invasive evaluation of chest pain in patients with angiographically normal coronary arteries">

                                <b>[23]</b>Lee BK, Yong AC, Fearon WF, et al.Invasive evalution of chest pain in patients with angiographically normal coronary arteries[J].Circulation, 2013, 128:A19113.
                            </a>
                        </p>
                        <p id="174">
                            <a id="bibliography_24" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Coronary microvascular dysfunction,microvascular angina,and management">

                                <b>[24]</b>Loffler AI, Bourque JM.Coronary microvascular dysfunction, microvascular angina, and management[J].Curr Cardiol Rep, 2016, 18 (1) :1-7.
                            </a>
                        </p>
                        <p id="176">
                            <a id="bibliography_25" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SSJD&amp;filename=SSJD00001063533&amp;v=MTcyMjV0SE5yNGxHWWVnTVkzazV6QmRoNGo5OVNYcVJyeG94Y01IN1I3cWRaK1p1RmlEbFU3elBJMWM9Tmo3QmFyTzRI&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[25]</b>Yamabe H, Namura H, Yano T, et al.Effect of nicorandil on abnormal coronary flow reserve assessed by exercise 201 (TI) scintigraphy in patients with angina pectoris and nearly coronary arteriograms[J].Cardiovasc Drugs Ther, 1995, 9 (6) :755-761.
                            </a>
                        </p>
                        <p id="178">
                            <a id="bibliography_26" target="_blank" href="http://scholar.cnki.net/result.aspx?q=The effects of nicorandil on microvascular function in patients with ST segment elevation myocardial infarction undergoing primary PCI">

                                <b>[26]</b>Kostic J, Diordjevic-Dikic A, Dobric M, et al.The effects of nicorandil on microvascular function in patients with ST segment elevation myocardial infarction undergoing primary PCI[J].Cardiovasc Ultrasound, 2015, 13:26.
                            </a>
                        </p>
                        <p id="180">
                            <a id="bibliography_27" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWD&amp;filename=SJWD15030400005085&amp;v=MDcwMDJzPU5pZmNhcks5SHRMTXE0OUZaT3NLREhROG9CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGMFRhUg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[27]</b>Tagliamonte E, Rigo F, Cirillo T, et al.Effects of ranolazine on nonivasive coronary flow reserve in patients with myocardial ischemia but without obstructive coronary artery disease[J].Echocardiography, 2015, 32 (3) :516-521.
                            </a>
                        </p>
                        <p id="182">
                            <a id="bibliography_28" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13080200177207&amp;v=MTY1MjZmT2ZiSzdIdG5Nclk5Rlpld0lEbncrb0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUYwVGFScz1OaQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[28]</b>Villano A, Di Franco A, Nerla R, et al.Effects of ivabradine and ranolazine in petients with microvascular angina pectoris[J].Am J Cardiol, 2013, 112 (1) :8-13
                            </a>
                        </p>
                        <p id="184">
                            <a id="bibliography_29" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJHD&amp;filename=SJHD14051200000444&amp;v=MjYxNTNycVFUTW53WmVadEZpbmxVcmZJSUYwVGFScz1OaWZEYXJLOEh0VE5yWTlGWk9zUENIZzlvQk1UNlQ0UFFIL2lyUmRHZQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[29]</b>Porro B, Eligini S, Veglia F, et al.Nitric oxide synthetic pathway in patients with microvascular angina and its relations with oxidative stress[J].Oxid Med Cell Longev, 2014, 2014:726539.
                            </a>
                        </p>
                        <p id="186">
                            <a id="bibliography_30" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=QKYL201301026&amp;v=MDc1MjVSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWptVkx6Qk5DYlNZckc0SDlMTXJvOUhZb1FLREg4NHY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[30]</b>徐辽杭, 卢亮.曲美他嗪治疗心脏X综合征疗效观察[J].全科医学临床与教育, 2013, 11 (1) :69-70
                            </a>
                        </p>
            </div>
        <!--reference end-->
        <!--footnote start-->
        <!--footnote end-->



    </div>

        <input id="fileid" type="hidden" value="XXGK201902030" />
        <input id="dpi" type="hidden" value="300" />
    </div>

<script>
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?6e967eb120601ea41b9d312166416aa6";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>

    


<input id="hid_uid" name="hid_uid" type="hidden" value="WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
<input id="hid_kLogin_headerUrl" name="hid_kLogin_headerUrl" type="hidden" value="/KLogin/Request/GetKHeader.ashx%3Fcallback%3D%3F" />
<input id="hid_kLogin_footerUrl" name="hid_kLogin_footerUrl" type="hidden" value="/KLogin/Request/GetKFooter.ashx%3Fcallback%3D%3F" />
<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201902030&amp;v=MDMxOTZaSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWptVkx6QlBUWE1aYkc0SDlqTXJZOUc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>
<div class="popflow" id="popupTips" style="display: none;">
    <div class="popflowArr"></div>
    <div class="popflowCot">
        <div class="hd"><a href="javascript:void(0);" onclick="$('#popupTips').hide();$('#popupmsg').html('')" class="close">X</a></div>
        <div class="bd">
            <p class="mes" id="popupmsg" name="popupmsg"></p>
          
        </div>
    </div>
</div>
<input type="hidden" id="myexport" value="//kns.cnki.net" />

<input type="hidden" id="KPCAPIPATH" value="//ishufang.cnki.net" />
<input type="hidden" id="CitedTimes" value="" />
<div class="link" id="GLSearch" style="display: none;">
    <i class="icon-trangle"></i>
    <div class="inner">
        <a class="icon" id="copytext">复制</a>
        <a class="icon" target="_blank" onclick="searchCRFD(this)">工具书搜索</a>
    </div>
</div>




<input id="hidVirtualPath" name="hidVirtualPath" type="hidden" value="/kxreader" />
<script src="/kxreader/bundles/detail?v=842_VlRz_g1CMCLi-M0twVw-4EOFG_noWyi_OsMnrAg1"></script>

<script src="/kxreader/Scripts/layer.min.js" type="text/javascript"></script>

<div id="footerBox" class="rootw footer">
</div>
<script>
    if (typeof FlushLogin == 'function') {
        FlushLogin();
    }
    modifyEcpHeader(true);
</script>

<!--图片放大功能 start-->
<script src="/kxreader/bundles/imagebox?v=W4phPu9SNkGcuPeJclikuVE3PpRyIW_gnfjm_19nynI1"></script>

<script type="text/javascript">
    $(function () {
        var j = $.noConflict();
        j(function () {
            j(".zoom-in,.btn-zoomin").imgbox({
                'alignment': 'center',
                'allowMultiple': false,
                'overlayShow': true
            });
        })
    });
</script>
<!--图片放大功能 end-->
<div class="fixedbar">
    <div class="backtop hiddenV" id="backtop">
        <a id="backTopSide" href="javascript:scroll(0,0);" title=""></a>
    </div>
</div>
<script type="text/javascript" src="/kxreader/Scripts/MathJax-2.6-latest/MathJax.js?config=MML_HTMLorMML-full"></script>

</body>
</html>
